title: Cafeteria diet-fed mice is a pertinent model of obesity-induced organ damage: a potential role of inflammation.
abstract: OBJECTIVE
  This study is aimed at evaluating the effects of a cafeteria diet (obesity) mouse model on early multi-organ functional, structural, endocrine and biochemical alterations.
  
  
  METHODS
  Multi-organ damage is assessed using clinical, biochemical, pathological, and inflammatory parameters in 30 mice fed one of the three diets for 15 weeks: standard chow diet (SC), high fat (HF), or "Cafeteria diet" (CAF) (standard SC and a choice of highly palatable human cafeteria foods: chocolate, biscuits, and peanut butter).
  
  
  RESULTS
  CAF diet was associated with an increase in body weight, energy intake, and serum cholesterol levels compared to the other diets, as well as higher insulin levels and lower glucose tolerance. Additionally, consumption of the CAF diet was associated with significantly higher weight gain, abdominal fat, and serum IL-6 levels, as well as more damage in the heart (coronary perivascular fibrosis and steatosis), kidney (chronic interstitial inflammation and glomerular sclerosis), and liver (liver weight, portal fibrosis, apoptosis, and steatosis) compared to the HF diet.
  
  
  CONCLUSIONS
  Functional and structural damage in CAF were higher than HF of similar macronutrient composition. This study provides a novel dietary model in mice that mimics multi-organ physiologic alterations in humans secondary to obesity.
authors.affiliation: Department of Natural Sciences, School of Arts and Sciences, Lebanese American University, PO Box 36, Byblos, Lebanon.
authors.forename: Nadine
authors.initials: N
authors.lastname: Zeeni
authors.forename: Carole
authors.initials: C
authors.lastname: Dagher-Hamalian
authors.forename: Hani
authors.initials: H
authors.lastname: Dimassi
authors.forename: Wissam H
authors.initials: WH
authors.lastname: Faour
mesh_terms: D050153:Abdominal Fat / Q000187:drug effects; D000818:Animals; D001823:Body Composition / Q000187:drug effects; D002784:Cholesterol / Q000097:blood; D004032:Diet; D059305:Diet, High-Fat / Q000009:adverse effects; D004703:Endocrine System / Q000473:pathology; D002149:Energy Intake / Q000187:drug effects; D005518:Food Preferences; D018149:Glucose Intolerance; D007249:Inflammation / Q000378:metabolism / Q000473:pathology*; D007328:Insulin / Q000097:blood; D015850:Interleukin-6 / Q000378:metabolism; D007668:Kidney / Q000473:pathology; D008099:Liver / Q000473:pathology; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009206:Myocardium / Q000473:pathology; D009765:Obesity / Q000378:metabolism / Q000473:pathology*; D009929:Organ Size / Q000187:drug effects; D015430:Weight Gain / Q000187:drug effects
chemical_list: D007328:Insulin; D015850:Interleukin-6; D002784:Cholesterol